GlassScriptPhysician profile
Andrew N Ramirez
NPI 1811942071
$12,683.50
in general payments reported to CMS, 2019-2025
51 companies · $2,647 in 2025
The $2,647 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $401 · 2022: $685 · 2023: $5,662 · 2024: $3,289 · 2025: $2,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,179 · Travel and Lodging: $2,288 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,179.28 |
| Travel and Lodging | $2,287.58 |
| Education | $130.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,289.29 | 2023-2025 | Linq II, Venaseal, Closurefast |
| Novartis Pharmaceuticals Corporation | $725.86 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $661.28 | 2021-2024 | Xarelto |
| Bard Peripheral Vascular, INC. | $645.48 | 2022-2025 | Venclose Maven Catheter |
| Heartflow, INC. | $599.98 | 2022-2025 | Ffrct |
| Actelion Pharmaceuticals US, INC. | $544.15 | 2024-2025 | Opsumit, Uptravi |
| Amgen INC. | $509.90 | 2021-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $509.06 | 2022-2025 | Varithena Administration Pack, Watchman |
| Shockwave Medical, INC | $467.57 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $404.92 | 2022-2025 | |
| C. R. Bard, INC. & Subsidiaries | $392.27 | 2023 | Venclose Maven Catheter |
| Merck Sharp & Dohme LLC | $385.02 | 2022-2025 | Verquvo, Winrevair |
| E.R. Squibb & Sons, L.L.C. | $355.12 | 2023-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $345.03 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Scpharmaceuticals INC. | $330.80 | 2023-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $276.37 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $273.36 | 2021-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $266.12 | 2022-2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $256.55 | 2025 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $217.40 | 2021-2025 | Farxiga, Wainua, Andexxa |
| Esperion Therapeutics, INC. | $174.77 | 2021-2025 | Nexletol |
| United Therapeutics Corporation | $158.53 | 2023-2025 | Tyvaso, Tyvaso, Orenitram |
| Smith+Nephew, INC. | $154.54 | 2023-2024 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Grafix Pl |
| Cvrx, INC. | $150.78 | 2023-2024 | Barostim Neo System |
| Angiodynamics, INC. | $148.59 | 2023-2025 | Smart Port Ct, Venacure 1470 Pro, Bioflo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.78 | 2022-2025 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $143.13 | 2024 | Arcalyst |
| Pfizer INC. | $141.69 | 2023-2024 | |
| W. L. Gore & Associates, INC. | $127.04 | 2025 | Gore Cardioform Septal Occluder |
| Regeneron Healthcare Solutions, INC. | $97.15 | 2025 | Evkeeza |
| Daiichi Sankyo INC. | $81.10 | 2023-2025 | Injectafer |
| Kestra Medical Technology Services, INC. | $77.55 | 2024-2025 | Assure Wcd |
| Abiomed | $65.88 | 2024-2025 | Impella |
| Sanofi-Aventis U.S. LLC | $59.73 | 2023-2024 | |
| Cleerly, INC. | $57.53 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Kowa Pharmaceuticals America, INC. | $55.44 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $42.57 | 2023-2024 | Inpefa |
| Arbor Pharmaceuticals, INC. | $41.43 | 2021 | |
| Bridgebio Pharma, INC. | $38.42 | 2025 | Attruby |
| Preventice Services, LLC | $33.34 | 2021 | |
| Baxter Healthcare | $27.66 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Edwards Lifesciences Corporation | $27.37 | 2025 | Sapien 3 Ultra Resilia |
| Ossur Americas, INC. | $26.08 | 2024 | |
| Inspire Medical Systems, INC. | $24.71 | 2024 | Inspire |
| Abbott Laboratories | $23.72 | 2024 | Jeti Peripheral Catheter |
| Kerecis Limited | $23.34 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Biowound Solutions, INC. | $20.12 | 2024 | Bio-Connekt |
| Atricure, INC. | $18.57 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Kiniksa Pharmaceuticals, LTD. | $15.80 | 2023 | Arcalyst |
| Azurity Pharmaceuticals, INC. | $15.66 | 2023 | Edarbi |
| Lundbeck LLC | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.